Open Access
Table 2
Types of cardiovascular diseases and dosing ratios of protamine-to-heparin.
| Valvular disorders | Ischemic heart disease (CABG only) | Valvular disorders + Ischemic heart disease | Ischemic heart disease + ventricular septal perforation | Aortic dissection | Aortic aneurysm | Others (VSD, ASD) | Patient number | ||
|---|---|---|---|---|---|---|---|---|---|
| No POAF | Dosing ratios of protamine-to-heparin = 1.0 | 33 | 3 | 4 | 0 | 9 | 4 | 4 | 57 |
| Dosing ratios of protamine-to-heparin >1.0 (up to 1.7) | 13 | 20 | 0 | 0 | 1 | 0 | 1 | 35 | |
| POAF | Dosing ratios of protamine-to-heparin = 1.0 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 5 |
| Dosing ratios of protamine-to-heparin >1.0 (up to 1.7) | 0 | 8 | 0 | 1 | 1 | 0 | 0 | 10 | |
| Patient number | 50 | 31 | 4 | 1 | 12 | 4 | 5 | 107 | |
POAF, postoperative atrial fibrillation; CABG, coronary artery bypass graft; VSD, ventricular septal defect; ASD, atrial septal defect.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.